Proven outcomes.1
Superior value.1,2
iFR is in a class of its own
Be confident in treatment and deferral decisions with Philips iFR.1,2
No other resting index has an ACC/AHA/SCAI Class IA recommendation based on the high level of clinical evidence for its accuracy. Philips iFR is the Gold Standard.1,2 iFR is the leading hyperemia-free physiologic index for measuring pressure in diagnostic and interventional procedures. Only offered by Philips, iFR is an evidence-based methodology that improves outcomes, saves time, and reduces patient discomfort.1,2,3 iFR Co-registration maps the physiologic measurements directly onto the angiogram enabling more complete procedural guidance.
Only Philips iFR has a Class IA recommendation by the ACC/AHA/SCAI and ESC1,3
Only iFR has clinically validated patient outcome data in the largest physiology studies ever
Only iFR has co-registration for advanced physiologic guidance
iFR is now available on the world's first solid core pressure guide wire
With an all new workhorse design, only OmniWire combines confidence in wire performance with proven iFR outcomes and iFR Co-registration, making it easy to benefit from physiology throughout the case.
Complex PCI with the world’s first solid core pressure wire
Master class in precision PCI with Drs. Allen Jeremias & Ziad Ali, utilizing the brand new OmniWire
First in human Complex PCI case with OmniWire – the world’s first solid core pressure wire with Dr. J. Singh
DEFINE PCI
Unseen focal lesions cause residual ischemia4
Only iFR has co-registration for advanced physiologic guidance
Map iFR values directly onto the angiogram, so you can see precisely which parts of a vessel are causing ischemia
Available on the new Philips IntraSight interventional applications platform and as an upgrade to the Core systems.
Why should you use iFR
Co-registration?
Improving PCI with iFR Co-registration
Dr. Justin Davies explains how iFR Co-registration can identify disease location and the likely impact of PCI before you stent.
Transforming how we do PCI with iFR Co-registration
Dr. Allen Jeremias explains the need to understand not just whether there is ischemia, but where it is when planning for PCI
Introducing IntraSight
Smart. Simple. Seamless.
Introducing the all-new Philips IntraSight interventional applications platform where imaging, physiology, co-registration3 and software come together to facilitate optimal patient care. IntraSight offers a comprehensive suite of clinically proven modalities, such as, iFR/FFR, IVUS and co-registration to simplify complex interventions, speed routine procedures and provide improved patient care.
Looking for the coronary suite offering?
1. Lawton J. et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. JACC. 2022;79(2):e21-e129. 2. Gotberg M, et al. Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis. Int J Cardiol 2021 1;344:54-59. 3. 2018 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;00:1-96. 4. Jeremias A et al. Blinded physiological assessment of residual ischemia after successful angiographic percutaneous coronary Intervention: The DEFINE PCI Study. JACC Cardiovasc Interv. 2019 Oct 28;12(20):1991-2001. 5. Co-registration tools available within IntraSight 7 configuration via SyncVision.
